New Research on Cystic Fibrosis Treatment Modalities at Jouf University

Strategic Insights -

Research conducted by Jouf University on cystic fibrosis has identified effective treatment modalities, including triple therapy and physiotherapy exercises, to reduce complications in children with the disease. The study also highlights the variable outcomes of nutritional interventions and emphasizes the need for reassessment. A comprehensive meta-analysis of existing research was conducted to determine the superiority of specific treatment modalities.

Key Takeaways:

  • Triple therapy, consisting of a combination of medications, achieved a significant reduction in CF-related complications, with an odds ratio (OR) of 0.29 and a relative risk (RR) of 0.54, accompanied by low heterogeneity (I² = 0% for both).
  • Physiotherapy and pulmonary exercises also yielded a beneficial effect, with an OR of 0.24 and an RR of 0.49, without heterogeneity.
  • Nutritional interventions revealed non-significant outcomes (OR = 6.91 and RR = 2.63), suggesting the need to re-evaluate these strategies.
  • Ivacaftor alone did not achieve statistical significance (OR = 0.34 and RR = 0.58), and the confidence intervals were broad, indicating uncertainty in the effect estimates.
  • Azithromycin exhibited a positive effect on CF management, with an OR of 2.37 and an RR of 1.54.
  • The overall pooled OR across all treatments was 0.71, with an RR not computed due to substantial heterogeneity (I²=93%).

Statistics:

  • The odds ratio (OR) of 0.29 for triple therapy indicates a 71% reduction in CF-related complications.
  • The relative risk (RR) of 0.54 for triple therapy also indicates a significant reduction in complications.
  • The OR of 0.24 for physiotherapy and pulmonary exercises indicates a 24% reduction in complications.
  • The RR of 0.49 for physiotherapy and pulmonary exercises also indicates a significant reduction in complications.

Sources:

  • A systematic review and meta-analysis of the treatment modalities available for children afflicted from cystic fibrosis. BMC Pediatrics, 2025,25(1):1-19. (BMC Pediatrics - https://bmcpediatr.biomedcentral.com)
  • NewsRx. Research Reports on Cystic Fibrosis from Jouf University Provide New Insights (A systematic review and meta-analysis of the treatment modalities available for children afflicted from cystic fibrosis). Respiratory Therapeutics Week. October 20, 2025; p 5156.